Related Experiment Video
Updated: May 8, 2026
12:02
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
14.0K
4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses
Atefeh Garzan1, S Kaleem Ahmed1, Nicole N Haese2
1Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States.
Journal of Medicinal Chemistry
|December 2, 2024
Summary
Researchers developed a new compound, N-(4-(3-((4-cyanophenyl)amino)phenyl)thiazol-2-yl)-2-(methylthio)nicotinamide (26), to combat Chikungunya virus (CHIKV). This potent inhibitor shows significant antiviral activity and improved stability.
Area of Science:
- Virology
- Medicinal Chemistry
- Drug Discovery
Background:
- Chikungunya virus (CHIKV) poses a significant global health threat.
- Existing treatments for CHIKV are limited, necessitating the development of novel antiviral agents.
- Compound 1 demonstrated initial promise as a CHIKV inhibitor.
Purpose of the Study:
- To optimize the antiviral potency and drug-like properties of CHIKV inhibitors.
- To discover and characterize novel compounds with enhanced efficacy against CHIKV.
- To elucidate the mechanism of action and evaluate the in vivo efficacy of lead compounds.
Main Methods:
- Structure-activity relationship (SAR) studies were conducted to guide compound optimization.
- Antiviral activity was assessed by measuring EC50, EC90, and viral titer reduction (VTR).
- Cytotoxicity was evaluated in normal human dermal fibroblast (NHDF) cells.
- Metabolic stability was determined using microsomal lipid metabolism (MLM) assays.
- Mechanism of action studies involved analyzing viral RNA translation and protein synthesis.
- In vivo efficacy was tested in a mouse model of CHIKV infection.
Main Results:
- Compound 1 exhibited moderate antiviral activity against CHIKV (EC50 = 0.6 μM) with low cytotoxicity (CC50 = 132 μM).
- Compound 26, derived from SAR studies, demonstrated significantly improved potency (EC90 = 0.45 μM) and efficacy (VTR = 8.7 logs).
- Compound 26 showed enhanced metabolic stability (t1/2 = 74 min) compared to Compound 1.
- Mechanism studies revealed that Compound 26 inhibits CHIKV replication by blocking viral RNA translation and protein synthesis.
- Compound 26 demonstrated efficacy in vivo against CHIKV infection in mice.
Conclusions:
- Compound 26 represents a potent and promising therapeutic candidate for Chikungunya virus infection.
- The optimized structure of Compound 26 offers improved antiviral activity, metabolic stability, and efficacy.
- Further investigation into Compound 26 warrants its development as a potential anti-CHIKV drug.
More Related Videos
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:22Preparation of 1° Amines: Azide Synthesis
Direct alkylation of ammonia produces polyalkylated amines, along with a quaternary ammonium salt. To exclusively prepare primary amines, the azide synthesis method can be used.
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...